Pulsed Electromagnetic Field Treatment With Dementia Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-100
SponsorHerrick Medical LLC
About this trial
An open label pilot study in mild to moderate AD/ADRD patients to assess the effects of treatment with ECHS AD/ADRD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over 120 days. Primary end point is the The Alzheimer's Disease Assessment Scale-Cognitive Subscale. Participants will be followed-up for 9 months post-treatment.
Eligibility criteria
Qualifiers
None
Disqualifiers
The patient lacks capacity to consent to study participation and no surrogate is available to provide consent
The patient does not have a study partner who would be available for interview
History of epileptic seizures or epilepsy
Has Frontotemporal Dementia
Trial design
Treatments tested in this trial
- ECHS AD Device
Treatment groups
48 Participants
are divided into 1 treatment groupSponsors and collaborators
Herrick Medical LLC
Lead sponsor
University of Miami
Collaborator
Source ClinicalTrials.gov